Precision Oncology Strategy in Trastuzumab-Resistant Human Epidermal Growth Factor Receptor 2–Positive Colon Cancer: Case Report of Durable Response to Ado-Trastuzumab Emtansine

Detalles Bibliográficos
Autores principales: Haslem, Derrick S., Ji, Hanlee P., Ford, James M., Nadauld, Lincoln D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2017
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446358/
https://www.ncbi.nlm.nih.gov/pubmed/32913966
http://dx.doi.org/10.1200/PO.16.00055

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446358/
https://www.ncbi.nlm.nih.gov/pubmed/32913966
http://dx.doi.org/10.1200/PO.16.00055

Ejemplares similares